Abstract
Objective To observe the clinical effect and safty of low molecular weight heparin calcium and edaravone in treating acute cerebel infarction. Methods 52 cases with acute cerebral infarction were randomly divided into 2 groups: comparative group( n = 25 ), which treated with Shuxuetong and CDP-C; treatment group (n = 27 ), which took as basic treatment, meanwhile treated with Edaravone and low molecular weight heparin calcium. The platelet count,FIB,PT were tested at the same time. Results At 7 d, 14 d,28 d after treatment, the Neurological Deficits Scale(NDS) and evaluating clinical curative effect were compared,the NDS and the total effective rate in treatment group were higher than those in the comparative group ( P ＜ 0.05 ). The FIB in treatment group were more decreased after treatment than before ( P ＜ 0.05 ). Conclusion Edaravone and low molecular weight heparin calcium all have significant clinical effect on acute cerebel infarction. It's safe to use. Key words: Low molecular weight heparin calcium; Edaravone; Acute; Cerebel infarction
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
